What We Make

High - Quality Tools Life Scientists Use to Seek Answers

Reagent " Tool Kits"

Specific combinations of chemistries that allow customers to carry out  laboratory tests in the fields of cell biology; DNA, RNA and protein analysis; drug development; human identification; and molecular diagnostics.

Integrated Systems

 Instrumentation that allows customers to automate their various research and lab procedures, increasing efficiency and precision.

Where Our Products Are Used

Pharmaceutical and Biotechnology Industries

Discovering new drugs to fight disease

Clinical and Molecular Diagnostics Laboratories

Detecting disease and determining therapies

Forensics and Paternity Laboratories

Discovering new drugs to fight disease

Government and Academic Research Laboratories

Discovering new drugs to fight disease

Applied Testing

Ensuring environmental food, water and plant safety and quality

Our Living Values

We have a 100 year mindset to keep asking questions that change the world. Promega exists on an evolutionary frontier where the values of science, business and human well-being intersect.

Read more about our purpose and values.

Integrated Systems

 Instrumentation that allows customers to automate their various research and lab procedures, increasing efficiency and precision.





Spend Less Time Budgeting & More Time

Discovering!



Histone Deacetylases Specifically Down-regulate p53-dependent Gene Act…

관리자
2022-04-26
조회수 14


Abstract

p53, the most commonly mutated gene in cancer cells, directs cell cycle arrest or induces programmed cell death (apoptosis) in response to stress. It has been demonstrated that p53 activity is up-regulated in part by posttranslational acetylation. In agreement with these observations, here we show that mammalian histone deacetylase (HDAC)-1, -2, and -3 are all capable of down-regulating p53 function. Down-regulation of p53 activity by HDACs is HDAC dosage-dependent, requires the deacetylase activity of HDACs, and depends on the region of p53 that is acetylated by p300/CREB-binding protein (CBP). These results suggest that interactions of p53 and HDACs likely result in p53 deacetylation, thereby reducing its transcriptional activity. In support of this idea, GST pull-down and immunoprecipitation assays show that p53 interacts with HDAC1 both in vitro andin vivo. Furthermore, a pre-acetylated p53 peptide was significantly deacetylated by immunoprecipitated wild type HDAC1 but not deacetylase mutant. Also, co-expression of HDAC1 greatly reduced the in vivo acetylation level of p53. Finally, we report that the activation potential of p53 on the BAX promoter, a natural p53-responsive system, is reduced in the presence of HDACs. Taken together, our findings indicate that deacetylation of p53 by histone deacetylases is likely to be part of the mechanisms that control the physiological activity of p53.


Abbreviations:

CBPCREB-binding proteinHDAChistone deacetylaseGSTglutathioneS-transferaseAbantibodyCATchloramphenicol acetyltransferasePREp53-responsive elementsBDPbenzotriazol-l-yloxytris(dimethylamino)phosphonium hexafluorophosphate


  • Received January 10, 2000.
  • Revision received March 24, 2000.
  • The American Society for Biochemistry and Molecular Biology, Inc.
0 0